Revision history of "Efficacy and Basic safety of Regorafenib in conjunction with Chemo because SecondLine Treatment within Sufferers with Metastatic Intestinal tract Cancer A new System MetaAnalysis along with Organized Literature Review"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 06:49, 18 February 2024Silkwound85 (Talk | contribs). . (3,419 bytes) (+3,419). . (Created page with "Non-inferiority, single middle, randomized medical trial (2017-2020). Sufferers have been randomized to obtain sometimes IC or perhaps Single pound during SSRF. The particular...")